Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cholangiopancreatography, Endoscopic Retrograde | 6 | 2001 | 62 | 0.440 |
Why?
|
Common Bile Duct Diseases | 2 | 1998 | 9 | 0.320 |
Why?
|
Sphincterotomy, Endoscopic | 3 | 2001 | 8 | 0.240 |
Why?
|
Pancreatic Pseudocyst | 3 | 2001 | 9 | 0.240 |
Why?
|
Stents | 5 | 2001 | 395 | 0.210 |
Why?
|
Pancreatic Ducts | 3 | 2001 | 28 | 0.210 |
Why?
|
Choledochal Cyst | 1 | 1998 | 5 | 0.160 |
Why?
|
Common Bile Duct | 1 | 1998 | 19 | 0.160 |
Why?
|
Sphincter of Oddi | 1 | 1998 | 2 | 0.160 |
Why?
|
Colonoscopes | 1 | 1998 | 13 | 0.150 |
Why?
|
Gastroenterostomy | 1 | 1998 | 7 | 0.150 |
Why?
|
Pancreatic Diseases | 1 | 1998 | 52 | 0.150 |
Why?
|
Aneurysm, False | 1 | 1997 | 54 | 0.150 |
Why?
|
Gastrointestinal Diseases | 1 | 1998 | 150 | 0.140 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1997 | 237 | 0.120 |
Why?
|
Drainage | 3 | 1998 | 159 | 0.110 |
Why?
|
Blood Proteins | 1 | 2011 | 145 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 73 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2011 | 112 | 0.090 |
Why?
|
Crohn Disease | 1 | 1996 | 756 | 0.080 |
Why?
|
Pancreatic Neoplasms | 1 | 2011 | 666 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2001 | 8178 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2001 | 3649 | 0.050 |
Why?
|
Biomarkers, Tumor | 1 | 2011 | 1532 | 0.050 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2001 | 7 | 0.050 |
Why?
|
Middle Aged | 6 | 2011 | 25787 | 0.050 |
Why?
|
Ampulla of Vater | 1 | 2001 | 23 | 0.050 |
Why?
|
Endoscopy, Digestive System | 1 | 2001 | 68 | 0.050 |
Why?
|
Mediastinum | 1 | 2001 | 47 | 0.050 |
Why?
|
Aged | 5 | 2011 | 19019 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2011 | 1849 | 0.040 |
Why?
|
Pancreas | 2 | 1998 | 244 | 0.040 |
Why?
|
Adult | 6 | 2011 | 26439 | 0.040 |
Why?
|
Adenoma | 1 | 2001 | 246 | 0.040 |
Why?
|
Male | 7 | 2011 | 42135 | 0.040 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 1998 | 8 | 0.040 |
Why?
|
Jejunoileal Bypass | 1 | 1998 | 6 | 0.040 |
Why?
|
Duodenum | 1 | 1997 | 103 | 0.040 |
Why?
|
Syndrome | 1 | 1998 | 449 | 0.040 |
Why?
|
Stomach | 1 | 1997 | 111 | 0.040 |
Why?
|
Postoperative Care | 1 | 1998 | 228 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2011 | 6758 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 1998 | 273 | 0.030 |
Why?
|
Parenteral Nutrition, Total | 1 | 1996 | 41 | 0.030 |
Why?
|
Sulfasalazine | 1 | 1996 | 34 | 0.030 |
Why?
|
Colonoscopy | 1 | 1998 | 279 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 1996 | 102 | 0.030 |
Why?
|
Humans | 9 | 2011 | 88852 | 0.030 |
Why?
|
Reoperation | 1 | 1998 | 598 | 0.030 |
Why?
|
Female | 6 | 2011 | 45899 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 1996 | 91 | 0.030 |
Why?
|
Steroids | 1 | 1996 | 174 | 0.030 |
Why?
|
Recurrence | 1 | 1998 | 1140 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 1997 | 262 | 0.030 |
Why?
|
Endoscopy | 1 | 1998 | 344 | 0.030 |
Why?
|
Databases, Factual | 1 | 1998 | 849 | 0.030 |
Why?
|
Retrospective Studies | 2 | 1998 | 8963 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 1998 | 1590 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 1996 | 343 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 1996 | 1146 | 0.020 |
Why?
|
Prognosis | 1 | 1998 | 3757 | 0.020 |
Why?
|
Time Factors | 1 | 1998 | 5313 | 0.020 |
Why?
|
ROC Curve | 1 | 2011 | 778 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2011 | 986 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 2013 | 0.020 |
Why?
|
Epinephrine | 1 | 2001 | 86 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 2001 | 56 | 0.010 |
Why?
|
Young Adult | 1 | 2011 | 6271 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 9201 | 0.010 |
Why?
|
Endosonography | 1 | 1998 | 98 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2001 | 2273 | 0.010 |
Why?
|